Found: 249
Select item for more details and to access through your institution.
The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat model.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1365151
- By:
- Publication type:
- Article
Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma.
- Published in:
- Current Treatment Options in Oncology, 2024, v. 25, n. 1, p. 127, doi. 10.1007/s11864-023-01153-5
- By:
- Publication type:
- Article
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes: A Mediation Analysis.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 12, p. 1606, doi. 10.7326/M23-1023
- By:
- Publication type:
- Article
Hypertension in chronic kidney disease—treatment standard 2023.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 12, p. 2694, doi. 10.1093/ndt/gfad118
- By:
- Publication type:
- Article
Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 10, p. 2358, doi. 10.1093/ndt/gfad074
- By:
- Publication type:
- Article
Prognostic Risk Stratification and End-of-Life Care Outcomes in Patients With Metastatic Melanoma Treated With Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. 911, doi. 10.1093/oncolo/oyad219
- By:
- Publication type:
- Article
Erratum. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA<sub>1c</sub> and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care 2022;45:888–897.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association.
- Published in:
- Cardiovascular Research, 2023, v. 119, n. 11, p. 2017, doi. 10.1093/cvr/cvad083
- By:
- Publication type:
- Article
The sodium‐glucose cotransporter‐2 inhibitor canagliflozin does not increase risk of non‐genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double‐blind trials
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2151, doi. 10.1111/dom.15091
- By:
- Publication type:
- Article
Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials.
- Published in:
- Journal of the American Heart Association, 2023, v. 12, n. 13, p. 1, doi. 10.1161/JAHA.122.028516
- By:
- Publication type:
- Article
Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies.
- Published in:
- Cancers, 2023, v. 15, n. 13, p. 3312, doi. 10.3390/cancers15133312
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1, doi. 10.1111/dom.15115
- By:
- Publication type:
- Article
Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1512, doi. 10.1111/dom.14999
- By:
- Publication type:
- Article
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1646, doi. 10.1111/dom.15019
- By:
- Publication type:
- Article
Feasibility and acceptability of an online intervention to enhance hopefulness among oncology professionals.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 3, p. 1, doi. 10.1093/jncics/pkad030
- By:
- Publication type:
- Article
Increased screening for elevated blood pressure, self-monitoring may reduce risk of CKD.
- Published in:
- Nephrology News & Issues, 2023, v. 37, n. 6, p. 16
- By:
- Publication type:
- Article
Should we CLICK on chlorthalidone for treatment-resistant hypertension in chronic kidney disease?
- Published in:
- Clinical Kidney Journal, 2023, v. 16, n. 5, p. 793, doi. 10.1093/ckj/sfac272
- By:
- Publication type:
- Article
Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE).
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 4, p. 894, doi. 10.1093/ndt/gfac198
- By:
- Publication type:
- Article
The Nonsteroidal Mineralocorticoid-Receptor-Antagonist Finerenone in Cardiorenal Medicine: A State-of-the-Art Review of the Literature.
- Published in:
- American Journal of Hypertension, 2023, v. 36, n. 3, p. 135, doi. 10.1093/ajh/hpac124
- By:
- Publication type:
- Article
Correlates of Taxane-Induced Neuropathy, an Electronic Health Record Based Observational Study.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 754, doi. 10.3390/cancers15030754
- By:
- Publication type:
- Article
A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease.
- Published in:
- Clinical Kidney Journal, 2023, v. 16, n. 2, p. 293, doi. 10.1093/ckj/sfac234
- By:
- Publication type:
- Article
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. C1, doi. 10.1111/dom.14960
- By:
- Publication type:
- Article
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon‐like peptide‐1 receptor agonist use.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 407, doi. 10.1111/dom.14883
- By:
- Publication type:
- Article
The foundation and the four pillars of treatment for cardiorenal protection in people with chronic kidney disease and type 2 diabetes.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 2, p. 253, doi. 10.1093/ndt/gfac331
- By:
- Publication type:
- Article
Accuracy of curability expectations in patients with gastrointestinal cancers.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 1, p. 20, doi. 10.1002/cam4.4947
- By:
- Publication type:
- Article
Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus.
- Published in:
- Clinical Kidney Journal, 2023, v. 16, n. 1, p. 30, doi. 10.1093/ckj/sfac187
- By:
- Publication type:
- Article
Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on cardiovascular outcomes in dialysis patients: a systematic review and meta-analysis.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 1, p. 203, doi. 10.1093/ndt/gfac253
- By:
- Publication type:
- Article
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.
- Published in:
- Diabetes Care, 2022, v. 45, n. 12, p. 2991, doi. 10.2337/dc22-0294
- By:
- Publication type:
- Article
Differential activity of wheat antioxidant defense system and alterations in the accumulation of osmolytes at different developmental stages as influenced by marigold (Tagetes erecta L.) leachates.
- Published in:
- Frontiers in Plant Science, 2022, v. 13, p. 1, doi. 10.3389/fpls.2022.1001394
- By:
- Publication type:
- Article
Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Pooled Secondary Analysis.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 10, p. e2236123, doi. 10.1001/jamanetworkopen.2022.36123
- By:
- Publication type:
- Article
Overall Adverse Event Profile of Vadadustat for the Treatment of Anemia Associated With Chronic Kidney Disease in Phase 3 Trials.
- Published in:
- American Journal of Nephrology, 2022, v. 53, n. 10, p. 701, doi. 10.1159/000528443
- By:
- Publication type:
- Article
Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 9, p. 1178, doi. 10.1002/ajh.26644
- By:
- Publication type:
- Article
Advances in the area of cardiorenal medicine: clinical research highlights from selected papers published in NDT.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 9, p. 1595, doi. 10.1093/ndt/gfac130
- By:
- Publication type:
- Article
Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Empagliflozin and incidence of events consistent with acute kidney injury: Pooled safety analysis in more than 15 000 individuals.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1390, doi. 10.1111/dom.14694
- By:
- Publication type:
- Article
Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 7, p. 1261, doi. 10.1093/ndt/gfab336
- By:
- Publication type:
- Article
A contemporary systematic review on liver transplantation for unresectable liver metastases of colorectal cancer.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 12, p. 2243, doi. 10.1002/cncr.34170
- By:
- Publication type:
- Article
Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO‐DKD trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 6, p. 996, doi. 10.1002/ejhf.2469
- By:
- Publication type:
- Article
Dr. Ramesh Chandra: An Icon of Plastic Surgery in India.
- Published in:
- Indian Journal of Plastic Surgery, 2022, v. 55, n. 3, p. 221, doi. 10.1055/s-0042-1743130
- By:
- Publication type:
- Article
Risk stratification and in-hospital outcome in patients with acute coronary syndrome.
- Published in:
- Journal of Family Medicine & Primary Care, 2022, v. 11, n. 6, p. 2780, doi. 10.4103/jfmpc.jfmpc_1805_21
- By:
- Publication type:
- Article
Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 6, p. 1014, doi. 10.1093/ndt/gfaa294
- By:
- Publication type:
- Article
Risk Factors for Fracture in Patients with Coexisting Chronic Kidney Disease and Type 2 Diabetes: An Observational Analysis from the CREDENCE Trial.
- Published in:
- Journal of Diabetes Research, 2022, p. 1, doi. 10.1155/2022/9998891
- By:
- Publication type:
- Article
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Spironolactone and chlorthalidone—old drugs, new uses—but approach with caution.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 3, p. 407, doi. 10.1093/ndt/gfab328
- By:
- Publication type:
- Article
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis.
- Published in:
- European Heart Journal, 2022, v. 43, n. 6, p. 474, doi. 10.1093/eurheartj/ehab777
- By:
- Publication type:
- Article
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP‐1RA treatment: A subgroup analysis from the FIDELIO‐DKD trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 125, doi. 10.1111/dom.14558
- By:
- Publication type:
- Article
NIH Funding, Research Productivity, and Scientific Impact: a 20-Year Study.
- Published in:
- JGIM: Journal of General Internal Medicine, 2022, v. 37, n. 1, p. 104, doi. 10.1007/s11606-021-06659-y
- By:
- Publication type:
- Article
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4891, doi. 10.1093/eurheartj/ehab497
- By:
- Publication type:
- Article
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and severe renal impairment.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 12, p. 2632, doi. 10.1111/dom.14513
- By:
- Publication type:
- Article
Sex difference in ambulatory blood pressure control associates with risk of ESKD and death in CKD patients receiving stable nephrology care.
- Published in:
- Nephrology Dialysis Transplantation, 2021, v. 36, n. 11, p. 2000, doi. 10.1093/ndt/gfab017
- By:
- Publication type:
- Article